Copyright Reports & Markets. All rights reserved.

Global Tardive Dyskinesia (TD) Treatment Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Tardive Dyskinesia (TD) Treatment Market Overview

      • 1.1 Product Overview and Scope of Tardive Dyskinesia (TD) Treatment
      • 1.2 Tardive Dyskinesia (TD) Treatment Segment by Type
        • 1.2.1 Global Tardive Dyskinesia (TD) Treatment Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Valbenazine
        • 1.2.3 Amantadine
        • 1.2.4 Tetrabenazine
        • 1.2.5 Clonazepam
        • 1.2.6 Others
      • 1.3 Tardive Dyskinesia (TD) Treatment Segment by Application
        • 1.3.1 Tardive Dyskinesia (TD) Treatment Consumption Comparison by Application (2014-2025)
        • 1.3.2 Hospitals
        • 1.3.3 Clinics
        • 1.3.4 Others
      • 1.4 Global Tardive Dyskinesia (TD) Treatment Market by Region
        • 1.4.1 Global Tardive Dyskinesia (TD) Treatment Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Tardive Dyskinesia (TD) Treatment Market Size
        • 1.5.1 Global Tardive Dyskinesia (TD) Treatment Revenue (2014-2025)
        • 1.5.2 Global Tardive Dyskinesia (TD) Treatment Production (2014-2025)

      2 Global Tardive Dyskinesia (TD) Treatment Market Competition by Manufacturers

      • 2.1 Global Tardive Dyskinesia (TD) Treatment Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Tardive Dyskinesia (TD) Treatment Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Tardive Dyskinesia (TD) Treatment Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Tardive Dyskinesia (TD) Treatment Production Sites, Area Served, Product Types
      • 2.5 Tardive Dyskinesia (TD) Treatment Market Competitive Situation and Trends
        • 2.5.1 Tardive Dyskinesia (TD) Treatment Market Concentration Rate
        • 2.5.2 Tardive Dyskinesia (TD) Treatment Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Tardive Dyskinesia (TD) Treatment Production Market Share by Regions

      • 3.1 Global Tardive Dyskinesia (TD) Treatment Production Market Share by Regions
      • 3.2 Global Tardive Dyskinesia (TD) Treatment Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Tardive Dyskinesia (TD) Treatment Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Tardive Dyskinesia (TD) Treatment Production
        • 3.4.1 North America Tardive Dyskinesia (TD) Treatment Production Growth Rate (2014-2019)
        • 3.4.2 North America Tardive Dyskinesia (TD) Treatment Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Tardive Dyskinesia (TD) Treatment Production
        • 3.5.1 Europe Tardive Dyskinesia (TD) Treatment Production Growth Rate (2014-2019)
        • 3.5.2 Europe Tardive Dyskinesia (TD) Treatment Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Tardive Dyskinesia (TD) Treatment Production (2014-2019)
        • 3.6.1 China Tardive Dyskinesia (TD) Treatment Production Growth Rate (2014-2019)
        • 3.6.2 China Tardive Dyskinesia (TD) Treatment Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Tardive Dyskinesia (TD) Treatment Production (2014-2019)
        • 3.7.1 Japan Tardive Dyskinesia (TD) Treatment Production Growth Rate (2014-2019)
        • 3.7.2 Japan Tardive Dyskinesia (TD) Treatment Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Tardive Dyskinesia (TD) Treatment Consumption by Regions

      • 4.1 Global Tardive Dyskinesia (TD) Treatment Consumption by Regions
      • 4.2 North America Tardive Dyskinesia (TD) Treatment Consumption (2014-2019)
      • 4.3 Europe Tardive Dyskinesia (TD) Treatment Consumption (2014-2019)
      • 4.4 China Tardive Dyskinesia (TD) Treatment Consumption (2014-2019)
      • 4.5 Japan Tardive Dyskinesia (TD) Treatment Consumption (2014-2019)

      5 Global Tardive Dyskinesia (TD) Treatment Production, Revenue, Price Trend by Type

      • 5.1 Global Tardive Dyskinesia (TD) Treatment Production Market Share by Type (2014-2019)
      • 5.2 Global Tardive Dyskinesia (TD) Treatment Revenue Market Share by Type (2014-2019)
      • 5.3 Global Tardive Dyskinesia (TD) Treatment Price by Type (2014-2019)
      • 5.4 Global Tardive Dyskinesia (TD) Treatment Production Growth by Type (2014-2019)

      6 Global Tardive Dyskinesia (TD) Treatment Market Analysis by Applications

      • 6.1 Global Tardive Dyskinesia (TD) Treatment Consumption Market Share by Application (2014-2019)
      • 6.2 Global Tardive Dyskinesia (TD) Treatment Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Tardive Dyskinesia (TD) Treatment Business

      • 7.1 Teva Pharma
        • 7.1.1 Teva Pharma Tardive Dyskinesia (TD) Treatment Production Sites and Area Served
        • 7.1.2 Tardive Dyskinesia (TD) Treatment Product Introduction, Application and Specification
        • 7.1.3 Teva Pharma Tardive Dyskinesia (TD) Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Biogen
        • 7.2.1 Biogen Tardive Dyskinesia (TD) Treatment Production Sites and Area Served
        • 7.2.2 Tardive Dyskinesia (TD) Treatment Product Introduction, Application and Specification
        • 7.2.3 Biogen Tardive Dyskinesia (TD) Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Johnson & Johnson
        • 7.3.1 Johnson & Johnson Tardive Dyskinesia (TD) Treatment Production Sites and Area Served
        • 7.3.2 Tardive Dyskinesia (TD) Treatment Product Introduction, Application and Specification
        • 7.3.3 Johnson & Johnson Tardive Dyskinesia (TD) Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 GlaxoSmithKline
        • 7.4.1 GlaxoSmithKline Tardive Dyskinesia (TD) Treatment Production Sites and Area Served
        • 7.4.2 Tardive Dyskinesia (TD) Treatment Product Introduction, Application and Specification
        • 7.4.3 GlaxoSmithKline Tardive Dyskinesia (TD) Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Neurocrine Biosciences
        • 7.5.1 Neurocrine Biosciences Tardive Dyskinesia (TD) Treatment Production Sites and Area Served
        • 7.5.2 Tardive Dyskinesia (TD) Treatment Product Introduction, Application and Specification
        • 7.5.3 Neurocrine Biosciences Tardive Dyskinesia (TD) Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Pfizer
        • 7.6.1 Pfizer Tardive Dyskinesia (TD) Treatment Production Sites and Area Served
        • 7.6.2 Tardive Dyskinesia (TD) Treatment Product Introduction, Application and Specification
        • 7.6.3 Pfizer Tardive Dyskinesia (TD) Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Novartis
        • 7.7.1 Novartis Tardive Dyskinesia (TD) Treatment Production Sites and Area Served
        • 7.7.2 Tardive Dyskinesia (TD) Treatment Product Introduction, Application and Specification
        • 7.7.3 Novartis Tardive Dyskinesia (TD) Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Sanofi
        • 7.8.1 Sanofi Tardive Dyskinesia (TD) Treatment Production Sites and Area Served
        • 7.8.2 Tardive Dyskinesia (TD) Treatment Product Introduction, Application and Specification
        • 7.8.3 Sanofi Tardive Dyskinesia (TD) Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 AstraZeneca
        • 7.9.1 AstraZeneca Tardive Dyskinesia (TD) Treatment Production Sites and Area Served
        • 7.9.2 Tardive Dyskinesia (TD) Treatment Product Introduction, Application and Specification
        • 7.9.3 AstraZeneca Tardive Dyskinesia (TD) Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Bayer AG
        • 7.10.1 Bayer AG Tardive Dyskinesia (TD) Treatment Production Sites and Area Served
        • 7.10.2 Tardive Dyskinesia (TD) Treatment Product Introduction, Application and Specification
        • 7.10.3 Bayer AG Tardive Dyskinesia (TD) Treatment Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served

      8 Tardive Dyskinesia (TD) Treatment Manufacturing Cost Analysis

      • 8.1 Tardive Dyskinesia (TD) Treatment Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Tardive Dyskinesia (TD) Treatment
      • 8.4 Tardive Dyskinesia (TD) Treatment Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Tardive Dyskinesia (TD) Treatment Distributors List
      • 9.3 Tardive Dyskinesia (TD) Treatment Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Tardive Dyskinesia (TD) Treatment Market Forecast

      • 11.1 Global Tardive Dyskinesia (TD) Treatment Production, Revenue Forecast
        • 11.1.1 Global Tardive Dyskinesia (TD) Treatment Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Tardive Dyskinesia (TD) Treatment Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Tardive Dyskinesia (TD) Treatment Price and Trend Forecast (2019-2025)
      • 11.2 Global Tardive Dyskinesia (TD) Treatment Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Tardive Dyskinesia (TD) Treatment Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Tardive Dyskinesia (TD) Treatment Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Tardive Dyskinesia (TD) Treatment Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Tardive Dyskinesia (TD) Treatment Production, Revenue Forecast (2019-2025)
      • 11.3 Global Tardive Dyskinesia (TD) Treatment Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Tardive Dyskinesia (TD) Treatment Consumption Forecast (2019-2025)
        • 11.3.2 Europe Tardive Dyskinesia (TD) Treatment Consumption Forecast (2019-2025)
        • 11.3.3 China Tardive Dyskinesia (TD) Treatment Consumption Forecast (2019-2025)
        • 11.3.4 Japan Tardive Dyskinesia (TD) Treatment Consumption Forecast (2019-2025)
      • 11.4 Global Tardive Dyskinesia (TD) Treatment Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Tardive Dyskinesia (TD) Treatment Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Tardive dyskinesia (TD) is a neurological disorder that has the involvement of the involuntary movements. The terms can be described as tardive which means delayed and dyskinesia which means abnormal movement. The symptoms of tardive dyskinesia include finger movement, facial grimacing, jaw swinging, repetitive chewing, continuous blinking of the eyes, tongue thrusting, and others. 

        The global Tardive Dyskinesia (TD) Treatment market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Tardive Dyskinesia (TD) Treatment volume and value at global level, regional level and company level. From a global perspective, this report represents overall Tardive Dyskinesia (TD) Treatment market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Teva Pharma
        Biogen
        Johnson & Johnson
        GlaxoSmithKline
        Neurocrine Biosciences
        Pfizer
        Novartis
        Sanofi
        AstraZeneca
        Bayer AG

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Valbenazine
        Amantadine
        Tetrabenazine
        Clonazepam
        Others

        Segment by Application
        Hospitals
        Clinics
        Others

        Buy now